[中药复方的适度整合平衡预设与中药研究中的药理学问题]

[Moderation-integrated-balance presupposition of Chinese medicine compound and pharmacological problems in traditional Chinese drug research].

作者信息

Zhao Jun-Ning

机构信息

Sichuan Academy of Chinese Medicine Sciences, Sichuan Center for Translational Medicine of Traditional Chinese Medicine, State Key Laboratory of Quality Evaluation of Traditional Chinese Medicine, Sichuan Geoherbs System Engineering Technology Research Center, Sichuan Provincial Key Laboratory of Quality Evaluation of Traditional Chinese Medicine and Innovative Chinese Medicine Research, Chengdu 610041, China.

出版信息

Zhongguo Zhong Yao Za Zhi. 2017 Mar;42(5):836-843. doi: 10.19540/j.cnki.cjcmm.2017.0027.

DOI:10.19540/j.cnki.cjcmm.2017.0027

PMID:28994522

Abstract

The moderation-integrated-balance presupposition (MIBP) of Chinese medicine compound was first proposed in this paper based on the review of function characteristics and action principles of Chinese medicine compound. Furthermore, the pharmacological problems of traditional Chinese drug research were discussed in details. The results were of important value in accelerating the transformation of traditional Chinese medicine compound, and constructing the new drug innovation and review system for traditional Chinese medicine.

摘要

本文在回顾中药复方功能特点和作用原理的基础上，首次提出了中药复方的“调控-整合-平衡”预设（MIBP）。此外，还详细讨论了中药研究中的药理学问题。研究结果对于加速中药复方的转化，构建中药新药创新与审评体系具有重要价值。